Canada markets closed

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.6900+0.0400 (+1.10%)
At close: 04:00PM EDT
3.7800 +0.09 (+2.44%)
After hours: 06:45PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-09-30
2022-09-30
2021-09-30
2020-09-30
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
40,334
43,717
37,916
32,984
25,232
Selling General and Administrative
11,331
12,039
13,070
9,018
5,857
Total Operating Expenses
51,665
55,731
50,986
41,948
30,938
Operating Income or Loss
-51,665
-55,731
-50,986
-41,948
-30,938
Interest Expense
-
964
0
0
-
Total Other Income/Expenses Net
2,327
2,678
2,419
4,281
4,501
Income Before Tax
-43,043
-47,498
-47,620
-37,641
-26,258
Income Tax Expense
112
7
358
268
22.664
Income from Continuing Operations
-43,155
-47,505
-47,978
-37,909
-26,280
Net Income
-43,155
-47,505
-47,978
-37,909
-26,280
Net Income available to common shareholders
-43,155
-47,505
-47,978
-37,909
-26,280
Basic EPS
-0.60
-0.60
-0.62
-0.54
-0.45
Diluted EPS
-0.60
-0.60
-0.62
-0.54
-0.45
Basic Average Shares
79,788
79,788
76,910
69,803
58,195
Diluted Average Shares
79,788
79,788
76,910
69,803
58,195